Free Access
Med Sci (Paris)
Volume 29, Number 1, Janvier 2013
Page(s) 28 - 30
Section Nouvelles
Published online 25 January 2013
  1. Millan MJ, Agid Y, Brune M, et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 2012 ; 11 : 141–168. [CrossRef] [PubMed] [Google Scholar]
  2. Codony X, Vela JM, Ramirez MJ. 5-HT(6) receptor and cognition. Curr Opin Pharmacol 2011 ; 11 : 94–100. [CrossRef] [PubMed] [Google Scholar]
  3. Johnson CN, Ahmed M, Miller ND. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia. Curr Opin Drug Discov Dev 2008 ; 11 : 642–654. [Google Scholar]
  4. Ivachtchenko AV, Ivanenkov YA, Tkachenko SE. 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey. Exp Opin Ther Pat 2010 ; 20 : 1171–1196. [CrossRef] [Google Scholar]
  5. Millan MJ, Marin P, Bockaert J, Mannoury la Cour C. Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci 2008 ; 29 : 454–464. [CrossRef] [PubMed] [Google Scholar]
  6. Bockaert J, Fagni L, Dumuis A, Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 2004 ; 103 : 203–221. [CrossRef] [PubMed] [Google Scholar]
  7. Meffre J, Chaumont-Dubel S, Mannoury la Cour C, et al. 5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol Med 2012 ; 4 : 1043–1056. [CrossRef] [PubMed] [Google Scholar]
  8. Le Bacquer O, Martineau Y, Mamane Y. Quand la traduction sort de sa TORpeur. Med Sci (Paris) 2006 ; 22 : 514–518. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Ehninger D, Silva AJ. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol Med 2011 ; 17 : 78–87. [CrossRef] [PubMed] [Google Scholar]
  10. Ehninger D, Han S, Shilyansky C, et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008 ; 14 : 843–848. [CrossRef] [PubMed] [Google Scholar]
  11. Jones CA, Watson DJ, Fone KC. Animal models of schizophrenia. Br J Pharmacol 2011 ; 164 : 1162–1194. [CrossRef] [PubMed] [Google Scholar]
  12. Pallet N, Beaune P, Thervet E, Legendre C, Anglicheau D. Inhibiteurs de mTOR : des antiprolifératifs pléiotropiques. Med Sci (Paris) 2006 ; 22 : 947–952. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.